LISA WOLSKE: Open Payments
NPI 1538670344 · DOWAGIAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 25 payments from 10 companies in 2025. Trend: 2023 $667 · 2024 $816 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $171 |
| Novo Nordisk Inc | 4 | $89 |
| Abbott Laboratories | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Boston Scientific Corporation | 2 | $39 |
| Lundbeck LLC | 1 | $28 |
| ABIOMED | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Leqembi, FREESTYLE LIBRE 3, Ozempic, WATCHMAN FLX, REXULTI, Rybelsus, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
